GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » YoY EPS Growth

Yumanity Therapeutics (FRA:8IY) YoY EPS Growth : 62.06% (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Yumanity Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2022 was 62.06%.

Yumanity Therapeutics's Earnings per Share (Diluted) for the three months ended in Sep. 2022 was €-0.31.

Yumanity Therapeutics YoY EPS Growth Historical Data

The historical data trend for Yumanity Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics YoY EPS Growth Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
YoY EPS Growth
- -537.35 80.84

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.63 70.07 -57.70 50.18 62.06

Yumanity Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Yumanity Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EPS Growth (A: Dec. 2021 )
=(Earnings per Share (Diluted) (A: Dec. 2021 )-Earnings per Share (Diluted) (A: Dec. 2020 ))/ | Earnings per Share (Diluted) (A: Dec. 2020 ) |
=(-3.398--17.731)/ | -17.731 |
=80.84 %

Yumanity Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2022 is calculated as:

YoY EPS Growth (Q: Sep. 2022 )
=(Earnings per Share (Diluted) (Q: Sep. 2022 )-Earnings per Share (Diluted) (Q: Sep. 2021 )) / | Earnings per Share (Diluted) (Q: Sep. 2021 )) |
=(-0.313--0.825)/ | -0.825 |
=62.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yumanity Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » YoY EPS Growth
Comparable Companies
CYTO ALNA BRTX KTRA ADTX STAB NBRV PSTV CYCC LEXX OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Website
https://www.yumanity.com
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines